• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Herbalife (HLF) Valuation Check After Mixed Share Price Performance And Turnaround Expectations

    Simply Wall St·04/04/2026 20:24:40
    Listen to the news

    Stock performance snapshot and recent context

    Herbalife (HLF) has moved sharply over different time frames, with a 3.5% decline over the past day, a 3.6% decline over the past week, a 14.2% decline over the past month, and an 8.3% gain over the past 3 months.

    Over longer horizons, the stock shows a 67.9% total return over the past year, alongside total return declines of 11.4% over three years and 69% over five years. This highlights mixed outcomes for different entry points.

    See our latest analysis for Herbalife.

    Herbalife's recent 1 month share price return decline of 14.15% contrasts with its 1 year total shareholder return of 67.96%, so recent momentum has faded after a strong rebound from earlier multi year weakness. At a share price of $13.89, the pullback can reflect investors reassessing growth potential in its health and wellness business or updating their view of risk after past volatility in the 3 year and 5 year total shareholder returns.

    If Herbalife has you thinking about where growth and risk might look different, it can be useful to widen the lens and scan other areas of the market with the 20 top founder-led companies

    With Herbalife trading at $13.89 and sitting at a reported 51% discount to one intrinsic value estimate, plus an 18% gap to analyst targets, is this a reset that opens a window, or is the market already pricing in future growth?

    Most Popular Narrative: 80% Undervalued

    Herbalife's fair value in the most followed narrative sits at $14 against a last close of $13.89, which frames a modest valuation gap and sets up a story driven by turnaround efforts, margin expectations, and how much change the market is pricing into the current quote.

    The analyst price target on Herbalife in our model has moved from US$12 to US$14, as analysts point to a recovery path supported by a healthier profit margin outlook, a slightly lower discount rate, and recent research highlighting ongoing business model improvements despite tempered revenue growth expectations and cautious sector valuations.

    Read the complete narrative.

    Curious what sits behind that move in fair value? The narrative leans on adjusted revenue expectations, a different margin profile, and a future earnings multiple that may surprise you.

    Result: Fair Value of $14 (UNDERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, you still need to weigh regulatory scrutiny of multi level marketing models and flat to declining volumes in several regions, both of which could pressure the turnaround story.

    Find out about the key risks to this Herbalife narrative.

    Next Steps

    With mixed signals around risk and reward, it helps to move quickly, review the facts for yourself, and weigh both sides using the 3 key rewards and 2 important warning signs

    Ready for more stock ideas?

    If Herbalife has sharpened your focus on risk, value and income potential, do not stop here. Broaden your watchlist with fresh ideas while they are still under the radar.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.